BLOOD PRESSURE MONITORING

Scope & Guideline

Innovating insights for a healthier tomorrow.

Introduction

Delve into the academic richness of BLOOD PRESSURE MONITORING with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1359-5237
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1996 to 2024
AbbreviationBLOOD PRESS MONIT / Blood Press. Monit.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'BLOOD PRESSURE MONITORING' aims to advance the understanding of blood pressure measurement, monitoring, and management across various populations and clinical settings. It emphasizes the importance of accurate measurement techniques, the role of technology in hypertension management, and the relationship between blood pressure and overall health outcomes.
  1. Blood Pressure Measurement Techniques:
    The journal focuses on the validation and accuracy of various blood pressure measurement devices and methodologies, including automated oscillometric devices, ambulatory blood pressure monitoring, and home monitoring systems.
  2. Hypertension Management and Treatment Strategies:
    Research published in this journal often explores different treatment protocols for hypertension, including pharmacological interventions, lifestyle modifications, and exercise regimens.
  3. Epidemiological Studies:
    The journal features studies that examine the prevalence and risk factors associated with hypertension across different demographics, including children, adults, and specific patient populations such as those with chronic diseases.
  4. Technological Innovations in Hypertension Monitoring:
    There is a consistent focus on the integration of new technologies, such as wearable devices and mobile applications, in the monitoring and management of blood pressure.
  5. Cardiovascular Risk Assessment:
    Many articles assess the relationship between blood pressure patterns (e.g., dipping vs. non-dipping) and cardiovascular outcomes, such as stroke and heart disease.
  6. Genetic and Biomarker Studies:
    The journal publishes research linking genetic factors and biomarkers, such as uric acid and C-reactive protein, to hypertension and its complications.
The journal has seen an increase in publications surrounding several emerging themes, reflecting the evolving landscape of hypertension research and technology.
  1. Integration of Artificial Intelligence and Machine Learning:
    Recent studies are increasingly exploring the application of AI and machine learning algorithms in predicting blood pressure changes and enhancing monitoring accuracy, demonstrating the intersection of technology and healthcare.
  2. Telemedicine and Remote Monitoring:
    There is a growing trend towards research on telehealth solutions and remote blood pressure monitoring, particularly in the context of increasing demand for home healthcare solutions.
  3. Impact of Comorbidities on Hypertension Management:
    Emerging research is focusing on how comorbid conditions, such as diabetes and cardiovascular diseases, influence blood pressure management strategies and outcomes.
  4. Longitudinal Studies on Blood Pressure Variability:
    There is a notable uptick in studies examining blood pressure variability over time and its implications for cardiovascular health, highlighting the need for dynamic management strategies.
  5. Role of Inflammation and Biomarkers:
    Research exploring the links between inflammatory markers and hypertension is gaining prominence, indicating a broader understanding of the pathophysiology of hypertension.
  6. Patient-Centric Approaches in Hypertension Management:
    Increasing emphasis is being placed on understanding patient behaviors, preferences, and adherence to treatment regimens, which is critical for improving hypertension outcomes.

Declining or Waning

In recent years, certain themes within the journal have shown a decrease in frequency or prominence. This could indicate a shift in research focus, funding priorities, or emerging interests in the field.
  1. Traditional Lifestyle Interventions:
    While lifestyle interventions like dietary changes and physical activity continue to be relevant, there is a noticeable decline in studies focused solely on these aspects, possibly due to a growing emphasis on technological solutions.
  2. Single-Factor Risk Assessments:
    Research focusing on isolated factors affecting blood pressure, such as single dietary components or singular lifestyle habits, is becoming less common as more comprehensive, multifactorial approaches gain traction.
  3. Basic Blood Pressure Monitoring in Stable Populations:
    Studies that primarily focus on monitoring blood pressure in stable populations without additional risk factors or conditions are becoming less prevalent, with more research directed towards complex patient profiles or high-risk groups.

Similar Journals

TRANSFUSION CLINIQUE ET BIOLOGIQUE

Elevating clinical practices through rigorous research.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 1246-7820Frequency: 4 issues/year

TRANSFUSION CLINIQUE ET BIOLOGIQUE, an esteemed journal published by Elsevier France - Éditions Scientifiques Médicales Elsevier, has been a pivotal resource in the fields of transfusion medicine, biochemistry, and hematology since its inception in 1994. With a strong commitment to advancing scientific knowledge, this journal provides a platform for high-quality research and clinical studies aimed at improving patient care and outcomes in transfusion practices. Although categorized in Q3 and Q4 quartiles across multiple categories in Biochemistry and Medicine for 2023, the journal holds significant potential for growth and impact within the scientific community. While it currently does not offer open access options, its indexing in reputable databases ensures visibility and reach among professionals and researchers. As the field evolves, TRANSFUSION CLINIQUE ET BIOLOGIQUE aims to continue fostering innovation and collaboration, making it a valuable tool for anyone involved in medical, biochemical, and hematological research.

Journal fur Hypertonie

Connecting researchers and practitioners in the fight against hypertension.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1028-2327Frequency: 2 issues/year

Journal fur Hypertonie is a leading academic journal published by KRAUSE & PACHERNEGG GMBH, dedicated to the critical field of hypertension research. Since its inception in 1998, the journal has served as a vital platform for disseminating pioneering studies and advancements in the diagnosis, treatment, and management of hypertension. Although its Scopus coverage was discontinued in 2016, the journal continues to hold significance within the academic community, evidenced by its ranking of #98 out of 124 in Internal Medicine, placing it in the 21st percentile. This reflects its targeted impact and relevance in the evolving landscape of cardiovascular research. With no Open Access options, the journal remains a specialized resource indispensable for researchers, healthcare professionals, and students focused on enhancing their understanding and clinical practices related to hypertension. The journal's address is MOZARTGASSE 10, GABLITZ 3003, AUSTRIA.

Integrated Blood Pressure Control

Exploring Innovative Solutions in Hypertension Control
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7104Frequency: 1 issue/year

Integrated Blood Pressure Control is a distinguished Open Access journal published by DOVE MEDICAL PRESS LTD in New Zealand, dedicated to advancing the field of cardiology and cardiovascular medicine as well as internal medicine. With its established timeline from 2009 to 2024, this journal has earned a commendable Q2 ranking in both its categories for 2023, reflecting its significant contribution to clinical research and practice. With an ISSN of 1178-7104, it provides a platform for high-quality, peer-reviewed articles that address the complexities of blood pressure management, aiming to improve patient outcomes and foster discussions among healthcare professionals. The journal's open-access model, implemented since 2008, ensures that research findings are readily available to all, promoting greater accessibility and dissemination of knowledge in this critical area of health. Researchers, professionals, and students alike are encouraged to engage with the latest findings and innovative practices published within this journal, which plays an essential role in shaping the future of blood pressure control and related medical fields.

TRANSFUSION MEDICINE REVIEWS

Unlocking insights in transfusion science.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-7963Frequency: 4 issues/year

TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.

Turkish Journal of Intensive Care-Turk Yogun Bakim Dergisi

Innovating Critical Care Through Research and Dialogue
Publisher: GALENOS PUBL HOUSEISSN: 2602-2974Frequency: 3 issues/year

The Turkish Journal of Intensive Care (Turk Yogun Bakim Dergisi), published by GALENOS PUBL HOUSE, is a premier, peer-reviewed open access journal dedicated to advancing the field of intensive care medicine. With its ISSN 2602-2974 and E-ISSN 2602-2974, this journal has been committed to providing high-quality research and clinical insights since its inception in 2002. The journal serves as a vital platform for professionals and researchers to disseminate innovative findings, explore emerging therapies, and discuss critical care practices, thereby contributing to enhanced patient outcomes in intensive care settings. Based in Istanbul, Turkey, it aims to foster an international dialogue among medical practitioners, researchers, and academicians dedicated to intensive care, ultimately contributing to the global body of knowledge in this crucial area of health care.

KIDNEY & BLOOD PRESSURE RESEARCH

Innovating Nephrology and Cardiovascular Medicine.
Publisher: KARGERISSN: 1420-4096Frequency: 12 issues/year

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

Neurosonology and Cerebral Hemodynamics

Innovating Ultrasound Techniques for Neurovascular Studies
Publisher: BULGARIAN SOC NEUROSONOLOGY & CEREBRAL HEMODYNAMICSISSN: 1312-6431Frequency: 2 issues/year

Neurosonology and Cerebral Hemodynamics is a notable academic journal published by the Bulgarian Society of Neurosonology & Cerebral Hemodynamics, dedicated to advancing the field of neurosonology and exploring the dynamics of cerebral blood flow. With an ISSN of 1312-6431, this journal serves as a vital platform for researchers, clinicians, and students interested in the latest methodologies and clinical applications related to ultrasound techniques in neurovascular studies. While the journal does not currently have open access options, it remains a respected source for peer-reviewed articles that contribute to both theoretical insights and practical advancements in neurosonology. The journal aims to disseminate cutting-edge research and foster collaboration among professionals in neurology, radiology, and vascular biology, thereby enhancing the understanding of cerebral hemodynamics in health and disease. As the field continues to evolve, Neurosonology and Cerebral Hemodynamics plays a critical role in shaping future research and clinical practices.

Blood Transfusion

Connecting Research with Clinical Practice in Hematology.
Publisher: SIMTIPRO SRLISSN: 1723-2007Frequency: 6 issues/year

Blood Transfusion is a leading journal in the fields of Hematology, Immunology, and Medicine, published by SIMTIPRO SRL in Italy. With its ISSN 1723-2007, the journal has established a significant presence in the academic community, as evidenced by its positioning within the Q2 category in Hematology and Medicine (miscellaneous) and Q3 in Immunology and Allergy for 2023. Notably, it ranks #38 out of 137 in the Hematology category, showcasing its impactful contributions to research and practice. Operating under a traditional publishing model, this journal provides valuable insights into advances in blood transfusion science, ultimately aimed at enhancing patient care and outcomes. Spanning from 2003 to 2024, the scope of Blood Transfusion covers a wide range of topics related to hematological and immunological research, making it an essential resource for researchers, healthcare professionals, and students engaged in these critical fields.

TRANSFUSION

Connecting Knowledge and Practice in Hematology
Publisher: WILEYISSN: 0041-1132Frequency: 12 issues/year

TRANSFUSION is a prestigious peer-reviewed journal published by WILEY, dedicated to advancing the field of hematology and transfusion medicine. With an ISSN of 0041-1132 and an E-ISSN of 1537-2995, this journal serves as a vital resource for researchers and professionals alike, delivering high-quality studies and reviews that impact clinical practice and blood management strategies. The journal enjoys a strong reputation, evidenced by its impressive Q1 ranking in hematology and Q2 in both immunology and allergy as of 2023. Covering foundational aspects from 1958 to 2024, TRANSFUSION not only provides valuable insights but also fosters collaboration and innovation in understanding the complexities of blood donation, transfusion practices, and immunological responses. With its significant contributions to the scientific community, this journal is essential for those seeking to stay at the forefront of research and advancements in transfusion science.

TRANSFUSION AND APHERESIS SCIENCE

Innovating Patient Care Through Apheresis and Transfusion Insights
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1473-0502Frequency: 6 issues/year

TRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.